Print
Susan Goodin, Pharm.D., FCCP, BCOP
Associate Director, Clinical Trials and Theraputics,
Director, Division of Pharmaceutical Sciences,
The Cancer Institute of New Jersey;
Professor of Medicine, Division of Medical Oncology,
UMDNJ-Robert Wood Johnson Medical School,
New Brunswick, New Jersey
After earning her doctorate in pharmacy from the University of Kentucky College of Pharmacy in Lexington, Dr. Goodin completed a Pharmacy Practice Residency at the University of Kentucky Medical Center in Lexington and an Oncology Pharmacy Residency at the Lucille P. Markey Cancer Center in conjunction with the University of Kentucky Medical Center. She is a Board Certified Oncology Pharmacist and was elected a Fellow of the American College of Clinical Pharmacy in October 2006.
With a research focus on the development of new drugs for the treatment and prevention of cancer, Dr. Goodin is the Clinical Leader for the Carcinogenesis and Chemoprevention Program at The Cancer Institute of New Jersey. Her other areas of research are in pharmacy practice, as well as the treatment of prostate cancer. An active clinician and researcher, she has given many presentations throughout the United States, Canada, and Europe, and her work has appeared in journals such as the American Journal of Health System Pharmacy, Cancer, Clinical Cancer Research, the Journal of Clinical Oncology, and the Journal of the American Pharmacy Association.
Currently, Dr. Goodin serves on the Board of Pharmaceutical Specialties, after serving on the Oncology Specialty Council for the last five years. She is an active member of several professional societies, including the American Society of Health-System Pharmacists, where she is a past chair for the Section of Clinical Specialists and Scientists, and recently served on the Science Task Force and the Practice Model Advisory Committee. In addition, she serves on the ASHP Foundation Research Advisory Committee. She is also active in the American College of Clinical Pharmacy, where she served on the programming committee of the 2008 Annual Meeting and chaired the Translation Science Track. Other professional societies involvement include the American Society of Clinical Oncologists, the Hematology Oncology Pharmacy Association, and the International Society of Oncology Pharmacy Practice.
About the lecture
"Looking through a Kaleidoscope: Translational Research and Pharmacy"
As with any discipline, research is critical to the advancement of pharmacy. Translational research opportunities in pharmacy exist, but we cannot limit ourselves to one approach, whether as a basic scientist or a clinical practitioner.
The key to our success in these research endeavors is developing collaborative relationships and listening to our patients as the research conducted by pharmacists can define new practices that shape routine patient care.
Quoted from the 2008-2009 Philip C. and Ethel F. Ashby Lecture Announcement Announcement Brochure